Vertex balding, plasma insulin-like growth factor 1, and insulin-like growth factor binding protein 3
June 2000
in “Journal of The American Academy of Dermatology”
TLDR Men with balding at age 45 had higher IGF-1 and lower IGFBP-3, suggesting these factors might be important in male pattern baldness.
The study, involving 431 men aged 47 to 81, found that those with vertex balding at age 45 had higher levels of insulin-like growth factor 1 (IGF-1) and lower levels of its binding protein (IGFBP-3). A 1 standard deviation increase in IGF-1 levels was associated with a 1.31 odds ratio for vertex balding, while a similar increase in IGFBP-3 levels was associated with a 0.62 odds ratio for balding. The findings suggest a potential role of the IGF-1 axis in male pattern hair loss, despite limitations such as the long time lapse since hair loss began and potential misclassification due to self-assessment. The study supports the idea that IGF-1 and IGFBP-3 may be important in the development of male pattern baldness.
View this study on jaad.org →
Cited in this study
research Finasteride in the treatment of men with androgenetic alopecia
Finasteride safely and effectively treats male pattern hair loss, but may cause reversible sexual issues and harm male fetuses.
research GROWTH FACTORS IN HAIR ORGAN DEVELOPMENT AND THE HAIR GROWTH CYCLE
Growth factors are crucial for hair development and could help treat hair diseases.
research Androgen Induction of Follicular Epithelial Cell Growth Is Mediated via Insulin-like Growth Factor-I from Dermal Papilla Cells
Male hormones promote hair cell growth by using a growth factor from nearby skin cells.
research Topical minoxidil in early male pattern baldness
Minoxidil promotes hair growth in male pattern baldness.